Mohamad-Ali Salloum is a Pharmacist and science writer. He loves simplifying science to the general public and healthcare students through words and illustrations. When he's not working, you can usually find him in the gym, reading a book, or learning a new skill.
Why ACE inhibitors cause cough?
Mohamad Ali Salloum, PharmD • May 11, 2022
Share
In this article, I will go briefly through the indications of ACEi and the background of this topic. Then I will discuss the mechanism of cough induction and how to clinically manage the patient. And lastly I will talk about interesting results from 2 studies.ACE inhibitors.
ACE is the abbreviation of angiotensin converting enzyme inhibitors.
This class of medications are used for several indications and they are:
1) Hypertension,
2) Left ventricular systolic dysfunction,
3) Acute myocardial infarction,
4) In patients who are at high risk of cardiovascular events,
5) In Diabetes mellitus and Renal Failure,
6) Scleroderma Renal Crisis.
To understand why ACE inhibitors can cause dry cough, let us first understand some of the physiology.. (Fig.1)
Angiotensinogen, which is primarily produced in the liver, is cleaved by Renin to Angiotensin 1.
And then angiotensin 1 is converted to angiotensin 2 , by the angiotensin converting enzyme (ACE)
ACE also inactivates Substance P.
Kininase II, is the enzyme that inactivates bradykinin and other potent vasodilator peptides. Scientists found that ACE is identical to Kininase II.
Thus, bradykinin is a molecule that is also cleaved by ACE into Inactive Peptides.
So when the ACE inhibitor is administered, it will block cleavage of both Ang I, Bradykinin, and Substance P. (Note that Bradykinin will also induce the release of Prostaglandins)
Inhibition of Ang II production lowers blood pressure and enhances natriuresis.
Inhibition of the degradation of bradykinin has beneficial antihypertensive and protective effects.
On the other hand, The increase in Bradykinin and Substance P levels will lead to the induction of dry cough.
In general ACE inhibitors are well tolerated, however, 5 to 20% of patients can suffer from cough.
The incidence of dry cough in patients receiving ACEIs vary among individual ACEIs, and is the lowest with perindopril. (1) (2)
The onset of ACE inhibitor-induced cough ranges from within hours of the first dose to months after the initiation of therapy. Resolution typically occurs within 1 to 4 weeks after the cessation of therapy, but cough may linger for up to 3 months (3)
So how Bradykinin and Substance P induce the dry cough?
Although the exact mechanism of ACEI-induced cough remains unclear, several theories have been postulated for cough development.
Accumulation of bradykinin and substance P in upper and lower respiratory tracts by ACEIs is the most widely accepted theory.
Bradykinin induces sensitization of airway sensory nerves via rapidly adapting stretch receptors and C-fiber receptors that releases neurokinin A and substance P. This causes airway smooth muscle to constrict leading to bronchoconstriction and cough. However, the reason why cough does not occur in all patients receiving ACEIs still warrants further research. (2)
Another method describes how cough is induced by Bradykinin is the Transient Potential Receptors (TPRs). Several types of TPR ion channels have been described on airway sensory nerves and may be activated by various mediators and physical factors, resulting in cough. TRPV1 (previously called the vanilloid receptor) is activated by capsaicin and bradykinin, all of which are potent tussive agents.
Overall, management of ACEI-induced cough can be done as per this algorithm: (Fig.2)
Other proposed methods to suppress the dry cough?
1) Iron supplementations (4)
2) Thromboxane antagonists, like Picotamide and Aspirin(5)
3) Intermediate but not low doses of aspirin probably can suppress ACEI-induced cough. (6)
4) Calcium channel blockers. (7)
Although it is proven that ACEIs can cause cough, check the results of these two interesting studies:
In a study, for a significant number of patients (27.4%), the cough spontaneously disappeared after 2–8 months of therapy despite continued and unaltered administration of ACEIs and without any therapy aimed for its suppression. All patients were followed up for 13 months after disappearance of cough, and no recurrences were observed. (8)
In another study by the same authors, >50% of patients developed complete resolution of symptoms despite continuing with treatment.(9)
So for sure, additional studies focused particularly on continuation of ACEIs and monitoring the development of cough in patients should be done to conclude and derive recommendations from them.
You can also watch the below video for better understanding of the topic:
Resources:
(1) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7670268/
(2) https://www.sciencedirect.com/science/article/pii/S0019483220301917
(3) https://journal.chestnet.org/article/S0012-3692(15)52845-6/fulltext
(4)https://www.ahajournals.org/doi/10.1161/01.hyp.38.2.166#:~:text=In%20conclusion%2C%20iron%20supplementation%20successfully,activity%20in%20bronchial%20epithelial%20cells
(5) https://pubmed.ncbi.nlm.nih.gov/9217714/
(6) https://pubmed.ncbi.nlm.nih.gov/10933569/
(7) https://doi.org/10.1016/S0011-393X(00)88520-3
(8) https://www.sciencedirect.com/science/article/abs/pii/000291499290630H
(9) https://europepmc.org/article/med/1433168
List of Services
ABOUT THE AUTHOR
Mohamad-Ali Salloum, PharmD
Share
Recent articles:
References: Gooley JJ, Chamberlain K, Smith KA, et al. Exposure to room light before bedtime suppresses melatonin onset and shortens melatonin duration in humans. J Clin Endocrinol Metab. 2011;96(3):E463‑E472. [academic.oup.com] Chang AM, Aeschbach D, Duffy JF, Czeisler CA. Evening use of light‑emitting eReaders negatively affects sleep, circadian timing, and next‑morning alertness. Proc Natl Acad Sci USA. 2015;112(4):1232‑1237. [hms.harvard.edu] Schöllhorn I, Stefani O, Lucas RJ, et al. Melanopic irradiance defines the impact of evening display light on sleep latency, melatonin and alertness. Commun Biol. 2023;6:1090. [nature.com] He J‑W, Tu Z‑H, Xiao L, Su T, Tang Y‑X. Effect of restricting bedtime mobile phone use on sleep, arousal, mood, and working memory: A randomized pilot trial. PLoS One. 2020;15(2):e0228756. [journals.plos.org] Hartstein LE, Mathew GM, Reichenberger DA, et al. The impact of screen use on sleep health across the lifespan: a National Sleep Foundation consensus statement. Sleep Health. 2024;10(4):373‑384. [sleephealt…ournal.org] Höhn C, Hahn MA, Gruber G, et al. Effects of evening smartphone use on sleep and declarative memory consolidation in male adolescents and young adults. Brain Commun. 2024;6(3):fcae173. Finucane E, O’Brien A, Treweek S, et al. Does reading a book in bed make a difference to sleep? The People’s Trial—an online, pragmatic randomized trial. Trials. 2021;22:873. [link.springer.com] Ong JC, Manber R, Segal Z, Xia Y, Shapiro S, Wyatt JK. A randomized controlled trial of mindfulness meditation for chronic insomnia. Sleep. 2014;37(9):1553‑1563. [academic.oup.com] , [mindfulchair.com] He X, Pan B, Ma N, et al. The association of screen time and the risk of sleep outcomes: a systematic review and meta‑analysis. Front Psychiatry. 2025;16:1640263. Shechter A, Quispe KA, Mizhquiri Barbecho JS, et al. Interventions to reduce short‑wavelength light at night and their effects on sleep: systematic review and meta‑analysis. SLEEP Advances. 2020;1(1):zpaa002. [academic.oup.com]
References: Harkin B, Webb TL, Chang BPI, Prestwich A, Conner M, Kellar I, et al. Does monitoring goal progress promote goal attainment? A meta-analysis of the experimental evidence. Psychol Bull . 2016;142(2):198–229. Available from: https://www.apa.org/pubs/journals/releases/bul-bul0000025.pdf Compernolle S, DeSmet A, Poppe L, Crombez G, De Bourdeaudhuij I, Cardon G, et al. Effectiveness of interventions using self-monitoring to reduce sedentary behavior in adults: a systematic review and meta-analysis. Int J Behav Nutr Phys Act . 2019;16(1):63. Available from: https://link.springer.com/article/10.1186/s12966-019-0824-3 Patel ML, Brooks TL, Bennett GG. Consistent self‑monitoring in a commercial app‑based intervention for weight loss: results from a randomized trial. J Behav Med . 2020;43:391–401. Available from: https://link.springer.com/article/10.1007/s10865-019-00091-8 Patel ML, Hopkins CM, Brooks TL, Bennett GG. Comparing self-monitoring strategies for weight loss in a smartphone app: randomized controlled trial. JMIR Mhealth Uhealth . 2019;7(2):e12209. Available from: https://mhealth.jmir.org/2019/2/e12209/ Lally P, Van Jaarsveld CHM, Potts HWW, Wardle J. How are habits formed: Modelling habit formation in the real world. Eur J Soc Psychol . 2010;40(6):998–1009. Available from: https://repositorio.ispa.pt/bitstream/10400.12/3364/1/IJSP_998-1009.pdf Singh B, Murphy A, Maher C, Smith AE. Time to form a habit: A systematic review and meta-analysis of health behaviour habit formation and its determinants. Healthcare (Basel) . 2024;12(23):2488. Available from: https://www.mdpi.com/2227-9032/12/23/2488 Gollwitzer PM, Sheeran P. Implementation intentions and goal achievement: A meta‑analysis of effects and processes. In: Advances in Experimental Social Psychology . 2006;38:69–119. Available from: https://www.researchgate.net/publication/37367696 Adriaanse MA, Gollwitzer PM, De Ridder DTD, De Wit JBF, Kroese FM. Breaking habits with implementation intentions: A test of underlying processes. Pers Soc Psychol Bull . 2011;37(4):502–13. Available from: https://dspace.library.uu.nl/bitstream/handle/1874/380229/0146167211399102.pdf Palmer CA, Bower JL, Cho KW, Clementi MA, Lau S, Oosterhoff B, et al. Sleep loss and emotion: A systematic review and meta-analysis of over 50 years of experimental research. Psychol Bull . 2023;149(11):2314–48. Available from: https://www.apa.org/pubs/journals/releases/bul-bul0000410.pdf Kong Y, Yu B, Guan G, Wang Y, He H. Effects of sleep deprivation on sports performance and perceived exertion in athletes and non-athletes: a systematic review and meta-analysis. Front Physiol . 2025;16:1544286. Available from: https://www.frontiersin.org/journals/physiology/articles/10.3389/fphys.2025.1544286/full Tadros M, Newby JM, Li S, Werner‑Seidler A. Psychological treatments to improve sleep quality in university students: systematic review and meta-analysis. PLoS One . 2025;20(2):e0317125. Available from: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0317125 Locke EA, Latham GP. Building a practically useful theory of goal setting and task motivation: A 35‑year odyssey. Am Psychol . 2002;57(9):705–17. Available from: https://med.stanford.edu/content/dam/sm/s-spire/documents/PD.locke-and-latham-retrospective_Paper.pdf
Reference: ACRP. “ICH E6(R2) to ICH E6(R3) Comparison.” (Jan 28, 2025) — terminology & essential records: PDF Clinical Trials Toolkit. “Summary of Key Changes in ICH E6(R3).” (Mar 25, 2025) — proportionality, QbD, safety reporting: Article PharmaEduCenter. “Key changes between ICH GCP E6 R3 and E6 R2.” (Aug 10, 2025) — structure & glossary: Blog CITI Program. “Navigating the Transition from ICH E6(R2) to ICH E6(R3).” (Mar 12, 2025) — consent & site practices: Blog IntuitionLabs. “ICH E6 (R3) Explained.” (Updated Jan 13, 2026) — rationale, data governance: Deep dive
Simplify your day with essentialism: set priorities, eliminate the non‑essential, time‑block deep work, and measure progress for stress‑free productivity.
A runner’s guide to VO₂ max: why plateaus happen and how to fix them with long intervals, tempo, hills, cross‑training and smart periodization.
Explore the science of cognitive dissonance and learn how attitude change occurs, why dissonance matters, and what recent brain studies reveal about decision-making and self-control.
Discover the science behind willpower and impulse control. Explore Dr. David Lewis’s “zombie brain” model, the ego depletion controversy, glucose myths, and evidence-based strategies like the 3-second pause, mindfulness, and environmental design to build lasting self-control.
Explore evidence-based insights into ACE inhibitors, calcium channel blockers, and ARBs for hypertension management.
Discover the latest scientific evidence (2022–2025) on Branched-Chain Amino Acids (BCAAs)—their role in muscle recovery, performance enhancement, and safety.